Drug Companies Cope with Declines, May Merge The recent merger of drug giants Aventis and Sanofi may only be the beginning of a new wave of consolidation in the drug industry, say observers. Companies are combining in an effort to cut costs -- a move that analysts say reflects a lack of new drugs. NPR's Snigdha Prakash reports.
NPR logo

Drug Companies Cope with Declines, May Merge

  • Download
  • <iframe src="https://www.npr.org/player/embed/1869210/1869211" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Drug Companies Cope with Declines, May Merge

Drug Companies Cope with Declines, May Merge

Drug Companies Cope with Declines, May Merge

  • Download
  • <iframe src="https://www.npr.org/player/embed/1869210/1869211" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The recent merger of drug giants Aventis and Sanofi may only be the beginning of a new wave of consolidation in the drug industry, say observers. Companies are combining in an effort to cut costs — a move that analysts say reflects a lack of new drugs. NPR's Snigdha Prakash reports.